EDGAR Filing Documents for 0001493152-15-006511

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001493152-15-006511

Filing Date

2015-12-31

Accepted

2015-12-31 16:54:04

Documents

Period of Report

2014-11-30

Document Format Files

Seq	Description	Document	Type	Size
1		form10-q.htm	10-Q	216480
2		ex31-1.htm	EX-31.1	14540
3		ex32-1.htm	EX-32.1	8043
	Complete submission text file	0001493152-15-006511.txt		975495

Data Files

Seq	Description	Document	Type	Size
4	XBRL INSTANCE FILE	ptlf-20141130.xml	EX-101.INS	85780
5	XBRL SCHEMA FILE	ptlf-20141130.xsd	EX-101.SCH	12320
6	XBRL CALCULATION FILE	ptlf-20141130_cal.xml	EX-101.CAL	19930
7	XBRL DEFINITION FILE	ptlf-20141130_def.xml	EX-101.DEF	24520
8	XBRL LABEL FILE	ptlf-20141130_lab.xml	EX-101.LAB	95258
9	XBRL PRESENTATION FILE	ptlf-20141130_pre.xml	EX-101.PRE	68183

Mailing Address 433 N. CAMDEN DR. BEVERLY HILLS CA 90210

Business Address 433 N. CAMDEN DR. BEVERLY HILLS CA 90210 (310) 279-5152

PetLife Pharmaceuticals, Inc. (Filer) CIK: 0001354591 (see all company filings)